Skip to main content
Growth HormoneVerified

Octreotide

Sandostatin · Octreotide acetate

A synthetic somatostatin analog approved for acromegaly and for symptoms associated with certain neuroendocrine tumours. It suppresses growth hormone release, the opposite direction to the secretagogues in this category.

Octreotide
Category
Growth Hormone
Half-life
~1.7-1.9 h, injection
Common vial
Varies
Regulatory
FDA approved

Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.

01

Regulatory status

FDA approved

The FDA has approved at least one product containing this substance for a specific medical use, which means it has been through the agency review process and carries an approved label. Approval is always for named indications in named populations, so it is not a statement that any other use has been evaluated.

A regulatory status describes paperwork, not safety. An approved compound can still be wrong for a given person, and an unapproved one is neither thereby dangerous nor thereby fine.

02

Half-life

~1.7-1.9 h, injection. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.

03

Storage & handling

Supplied as a solution in a single-dose vial; refrigerated and protected from light per its label.

04

References

  • FDA label: octreotide acetate injection (ANDA 075957)

Read the source

Common questions

Octreotide, answered plainly.

01What is Octreotide?+

A synthetic somatostatin analog approved for acromegaly and for symptoms associated with certain neuroendocrine tumours. It suppresses growth hormone release, the opposite direction to the secretagogues in this category. It is also referred to as Sandostatin, Octreotide acetate. It is listed here under Growth Hormone as educational reference, which is not a recommendation to use it.

02Is Octreotide FDA approved?+

FDA approved. The FDA has approved at least one product containing this substance for a specific medical use, which means it has been through the agency review process and carries an approved label. Approval is always for named indications in named populations, so it is not a statement that any other use has been evaluated.

03What is the half-life of Octreotide?+

~1.7-1.9 h, injection. A half-life is an educational pharmacology figure describing how long the body takes to clear half of a substance. It is not a schedule and does not imply one.

04How is Octreotide stored and handled?+

Supplied as a solution in a single-dose vial; refrigerated and protected from light per its label. Storage conditions come from a manufacturer's own label where one exists, and a compound with no approved label has no agency-reviewed handling instructions at all.

Compare Octreotide

Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.